We are live on ! Find out more
IQMDW

Intelligent Medicine Acquisition Corp. Warrant
IQMDW

Delisted

IQMDW was delisted on the 26th of April, 2023.

Back to rankings

42 hedge funds and large institutions have $2.66M invested in Intelligent Medicine Acquisition Corp. Warrant in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

5% more funds holding

Funds holding: 40 → 42 (+2)

26% less capital invested

Capital invested by funds: $3.62M → $2.66M (-$958K)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
42
Holders Change
+2
Holders Change %
+5%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
5
Closed
2
Calls
$23K
Puts
–
Net Calls
+$23K
Net Calls Change
+$10K

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$11.8K
2
AGM
Alpine Global Management
New York
+$11.1K
3
EFI
EHP Funds Inc
Canada
+$10.3K
4
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
+$2.53K
5
QGA
Q Global Advisors
Texas
+$848

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$83K
2
Walleye Capital
Walleye Capital
New York
-$852
3
Goldman Sachs
Goldman Sachs
New York
-$560
4
FTCM
Fir Tree Capital Management
New York
-$86
5
SCM
Shaolin Capital Management
Florida
-$57
Name Holding Trade Value Shares
Change 		Change in
Stake
PMAM
26
Picton Mahoney Asset Management
Ontario, Canada
$12K – – –
Hudson Bay Capital Management
27
Hudson Bay Capital Management
Connecticut
$10K – – –
CCM
28
Context Capital Management
California
$9K – – –
CS
29
Clear Street
New York
$8K +$11.8K +58,134 New
Walleye Capital
30
Walleye Capital
New York
$7K -$852 -4,210 -7%
CH
31
CVI Holdings
Delaware
$7K – – –
DKCM
32
Davidson Kempner Capital Management
New York
$7K – – –
AGM
33
Alpine Global Management
New York
$7K +$11.1K +54,800 New
WAM
34
Wolverine Asset Management
Illinois
$5K – – –
AC
35
Antara Capital
New York
$4K – – –
Walleye Trading
36
Walleye Trading
New York
$4K – – –
ASM
37
ATW SPAC Management
New York
$2K – – –
CC
38
Centiva Capital
New York
$2K – – –
DCM
39
Dupont Capital Management
Delaware
$2K – – –
SAMU
40
SONA Asset Management (US)
New York
$2K – – –
WP
41
Woodline Partners
California
$2K – – –
COPPSERS
42
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$2K +$2.53K +12,500 New
Citadel Advisors
43
Citadel Advisors
Florida
– -$83K -300,000 Closed
SCC
44
Spring Creek Capital
Kansas
– -$35K -125,000 Closed
1
2

IQMDW Hedge Fund Activity: Q2 2022 in Review

42 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Warrant (IQMDW) for Q2 2022, worth a combined $2.66M — down 26% from $3.62M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new IQMDW positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 5 trimmed.

The largest buyer was Clear Street, opening a new position worth an estimated $11.8K. The largest seller was Citadel Advisors, exiting entirely with an estimated $83K sold.

  • 42 institutional investors held Intelligent Medicine Acquisition Corp. Warrant (IQMDW) as of Q2 2022, up from 40 in Q1 2022.
  • Funds reported $2.66M of Intelligent Medicine Acquisition Corp. Warrant stock for Q2 2022, down 26% quarter-over-quarter.
  • 4 funds opened new Intelligent Medicine Acquisition Corp. Warrant positions in Q2 2022 and 2 closed out, a net change of +2 holders.
  • The largest Intelligent Medicine Acquisition Corp. Warrant buyer in Q2 2022 was Clear Street, an estimated $11.8K added.
  • The largest Intelligent Medicine Acquisition Corp. Warrant seller in Q2 2022 was Citadel Advisors, an estimated $83K sold.

Based on aggregated 13F filings for Q2 2022.